Keywords
Last Name

Arthur C. Theodore, MD

TitleAssociate Professor
InstitutionBoston University School of Medicine
DepartmentMedicine
DivisionPulmonary, Allergy, Sleep & Critical Care Medicine
Address72 E. Concord St Housman (R)
Boston MA 02118
Phone(617) 638-4933
ORCID ORCID Icon0000-0003-0740-4481
Other Positions
TitleActive Staff Privileges
InstitutionBoston Medical Center
DepartmentMedicine

 Research Expertise & Professional Interests
My expertise in presentation of scientific data, bedside education, communication and negotiation, conflict resolution, curriculum development, leading teams and meetings, solving problems, researching and presenting medical literature, quality improvement, strategic planning, delivering health care and comprehending law and ethics results from 14 years as Director of the Medical Intensive Care Unit, 31 years as an academic physician dedicated to education, research and clinical care, 6 years participation in the Ethics Committee and production of over 200 opinions and testimony in personal injury and medical malpractice.

 Self-Described Keywords
  • Systemic Sclerosis Intersititial Lung Disease
 Publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Tashkin DP, Volkmann ER, Tseng CH, Roth MD, Khanna D, Furst DE, Clements PJ, Theodore A, Kafaja S, Kim GH, Goldin J, Ariolla E, Elashoff RM. Improved Cough and Cough-Specific Quality of Life in Patients Treated for Scleroderma-Related Interstitial Lung Disease: Results of Scleroderma Lung Study II. Chest. 2017 Apr; 151(4):813-820. PMID: 28012804.
    View in: PubMed
  2. Tashkin DP, Roth MD, Clements PJ, Furst DE, Khanna D, Kleerup EC, Goldin J, Arriola E, Volkmann ER, Kafaja S, Silver R, Steen V, Strange C, Wise R, Wigley F, Mayes M, Riley DJ, Hussain S, Assassi S, Hsu VM, Patel B, Phillips K, Martinez F, Golden J, Connolly MK, Varga J, Dematte J, Hinchcliff ME, Fischer A, Swigris J, Meehan R, Theodore A, Simms R, Volkov S, Schraufnagel DE, Scholand MB, Frech T, Molitor JA, Highland K, Read CA, Fritzler MJ, Kim GH, Tseng CH, Elashoff RM. Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial. Lancet Respir Med. 2016 Sep; 4(9):708-19. PMID: 27469583.
    View in: PubMed
  3. Raghu G, Rochwerg B, Zhang Y, Garcia CA, Azuma A, Behr J, Brozek JL, Collard HR, Cunningham W, Homma S, Johkoh T, Martinez FJ, Myers J, Protzko SL, Richeldi L, Rind D, Selman M, Theodore A, Wells AU, Hoogsteden H, Schünemann HJ. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis. An Update of the 2011 Clinical Practice Guideline. Am J Respir Crit Care Med. 2015 Jul 15; 192(2):e3-19. PMID: 26177183.
    View in: PubMed
  4. Theodore AC, Tseng CH, Li N, Elashoff RM, Tashkin DP. Correlation of cough with disease activity and treatment with cyclophosphamide in scleroderma interstitial lung disease: findings from the Scleroderma Lung Study. Chest. 2012 Sep; 142(3):614-21. PMID: 22156609.
    View in: PubMed
  5. Theodore AC, Wilson KC. An unseen danger: frequency of posterior vessel wall penetration by needles during attempts to place internal jugular vein central catheters using ultrasound guidance. Crit Care Med. 2010 Jan; 38(1):345-6; author reply 346-7. PMID: 20023505.
    View in: PubMed
  6. Au K, Khanna D, Clements PJ, Furst DE, Tashkin DP. Current concepts in disease-modifying therapy for systemic sclerosis-associated interstitial lung disease: lessons from clinical trials. Curr Rheumatol Rep. 2009 Apr; 11(2):111-9. PMID: 19296883.
    View in: PubMed
  7. Marshall J, Finn CA, Theodore AC. Impact of a clinical pharmacist-enforced intensive care unit sedation protocol on duration of mechanical ventilation and hospital stay. Crit Care Med. 2008 Feb; 36(2):427-33. PMID: 18091554.
    View in: PubMed
  8. Strange C, Bolster MB, Roth MD, Silver RM, Theodore A, Goldin J, Clements P, Chung J, Elashoff RM, Suh R, Smith EA, Furst DE, Tashkin DP. Bronchoalveolar lavage and response to cyclophosphamide in scleroderma interstitial lung disease. Am J Respir Crit Care Med. 2008 Jan 1; 177(1):91-8. PMID: 17901414.
    View in: PubMed
  9. Tashkin DP, Elashoff R, Clements PJ, Roth MD, Furst DE, Silver RM, Goldin J, Arriola E, Strange C, Bolster MB, Seibold JR, Riley DJ, Hsu VM, Varga J, Schraufnagel D, Theodore A, Simms R, Wise R, Wigley F, White B, Steen V, Read C, Mayes M, Parsley E, Mubarak K, Connolly MK, Golden J, Olman M, Fessler B, Rothfield N, Metersky M, Khanna D, Li N, Li G. Effects of 1-year treatment with cyclophosphamide on outcomes at 2 years in scleroderma lung disease. Am J Respir Crit Care Med. 2007 Nov 15; 176(10):1026-34. PMID: 17717203.
    View in: PubMed
  10. Khanna D, Yan X, Tashkin DP, Furst DE, Elashoff R, Roth MD, Silver R, Strange C, Bolster M, Seibold JR, Riley DJ, Hsu VM, Varga J, Schraufnagel DE, Theodore A, Simms R, Wise R, Wigley F, White B, Steen V, Read C, Mayes M, Parsley E, Mubarak K, Connolly MK, Golden J, Olman M, Fessler B, Rothfield N, Metersky M, Clements PJ. Impact of oral cyclophosphamide on health-related quality of life in patients with active scleroderma lung disease: results from the scleroderma lung study. Arthritis Rheum. 2007 May; 56(5):1676-84. PMID: 17469162.
    View in: PubMed
  11. Clearment, G and AC Theodore. Arterial Catheterization. In: UpToDate, Rose, BD (Ed), UpToDate. Waltham. MA. 2007.
  12. Theodore, AC. . Arterial Blood Gasses. In: UpToDate, Rose, BD (Ed), UpToDate,. Waltham. MA. 2007.
  13. Theodore, AC and LS Jefferson. . Oxygenation and mechanisms of hypoxemia. In: UpToDate, Rose, BD (Ed), UpToDate. Waltham. MA,. 2007.
  14. Tashkin DP, Elashoff R, Clements PJ, Goldin J, Roth MD, Furst DE, Arriola E, Silver R, Strange C, Bolster M, Seibold JR, Riley DJ, Hsu VM, Varga J, Schraufnagel DE, Theodore A, Simms R, Wise R, Wigley F, White B, Steen V, Read C, Mayes M, Parsley E, Mubarak K, Connolly MK, Golden J, Olman M, Fessler B, Rothfield N, Metersky M. Cyclophosphamide versus placebo in scleroderma lung disease. N Engl J Med. 2006 Jun 22; 354(25):2655-66. PMID: 16790698.
    View in: PubMed
  15. Wilson KC, Reardon C, Theodore AC, Farber HW. Propylene glycol toxicity: a severe iatrogenic illness in ICU patients receiving IV benzodiazepines: a case series and prospective, observational pilot study. Chest. 2005 Sep; 128(3):1674-81. PMID: 16162774.
    View in: PubMed
  16. Khanna D, Clements PJ, Furst DE, Chon Y, Elashoff R, Roth MD, Sterz MG, Chung J, FitzGerald JD, Seibold JR, Varga J, Theodore A, Wigley FM, Silver RM, Steen VD, Mayes MD, Connolly MK, Fessler BJ, Rothfield NF, Mubarak K, Molitor J, Tashkin DP. Correlation of the degree of dyspnea with health-related quality of life, functional abilities, and diffusing capacity for carbon monoxide in patients with systemic sclerosis and active alveolitis: results from the Scleroderma Lung Study. Arthritis Rheum. 2005 Feb; 52(2):592-600. PMID: 15692967.
    View in: PubMed
  17. Center DM, Cruikshank WW, Parada NA, Ryan T, Theodore AC, Viglianti G, Lim KG, Weller PF. Measurement of interleukin 16. Curr Protoc Immunol. 2001 May; Chapter 6:Unit 6.23. PMID: 18432814.
    View in: PubMed
  18. Reardon C, and Theodore, AC. . “Lung Cancer.”. A Practical Approach to Pulmonary Medicine: ed. by R. Goldstein and J. Karlinsky. Lipincott-Raven. Philadelphia,. 1997.
  19. Cruikshank WW, Lim K, Theodore AC, Cook J, Fine G, Weller PF, Center DM. IL-16 inhibition of CD3-dependent lymphocyte activation and proliferation. J Immunol. 1996 Dec 15; 157(12):5240-8. PMID: 8955168.
    View in: PubMed
  20. Theodore AC, Center DM, Nicoll J, Fine G, Kornfeld H, Cruikshank WW. CD4 ligand IL-16 inhibits the mixed lymphocyte reaction. J Immunol. 1996 Sep 1; 157(5):1958-64. PMID: 8757315.
    View in: PubMed
  21. Center DM, Berman JS, Kornfeld H, Theodore AC, Cruikshank WW. The lymphocyte chemoattractant factor. J Lab Clin Med. 1995 Feb; 125(2):167-72. PMID: 7844466.
    View in: PubMed
  22. Center DM, Kornfeld H, Wu MJ, Falvo M, Theodore AC, Bernardo J, Berman JS, Cruikshank WW, Djukanovic R, Teran L, et al. Cytokine binding to CD4+ inflammatory cells: implications for asthma. Am J Respir Crit Care Med. 1994 Nov; 150(5 Pt 2):S59-62. PMID: 7952594.
    View in: PubMed
  23. Theodore AC, Kornfeld H, Wallace RP, Cruikshank WW. CD4 modulation of noninfected human T lymphocytes by HIV-1 envelope glycoprotein gp120: contribution to the immunosuppression seen in HIV-1 infection by induction of CD4 and CD3 unresponsiveness. J Acquir Immune Defic Syndr. 1994 Sep; 7(9):899-907. PMID: 7914230.
    View in: PubMed
  24. Cruikshank WW, Center DM, Nisar N, Wu M, Natke B, Theodore AC, Kornfeld H. Molecular and functional analysis of a lymphocyte chemoattractant factor: association of biologic function with CD4 expression. Proc Natl Acad Sci U S A. 1994 May 24; 91(11):5109-13. PMID: 7910967.
    View in: PubMed
  25. Center DM, Berman JS, Kornfeld H, Theodore AC, Cruikshank WW. Mechanisms of lymphocyte accumulation in pulmonary disease. Chest. 1993 Feb; 103(2 Suppl):88S-91S. PMID: 8094048.
    View in: PubMed
  26. Cruikshank WW, Greenstein JL, Theodore AC, Center DM. Lymphocyte chemoattractant factor induces CD4-dependent intracytoplasmic signaling in lymphocytes. J Immunol. 1991 May 1; 146(9):2928-34. PMID: 1673145.
    View in: PubMed
  27. Berman JS, Beer DJ, Theodore AC, Kornfeld H, Bernardo J, Center DM. Lymphocyte recruitment to the lung. Am Rev Respir Dis. 1990 Jul; 142(1):238-57. PMID: 2195933.
    View in: PubMed
  28. Berman JS, Cruikshank WW, Beer DJ, Kornfeld H, Bernardo J, Theodore AC, Center DM. Lymphocyte motility and lymphocyte chemoattractant factors. Immunol Invest. 1988 Nov-Dec; 17(8-9):625-77. PMID: 3068125.
    View in: PubMed
  29. Beer DJ, Cruikshank WW, Berman JS, Theodore AC, Center DM. . “Histamine-Induced Human Lymphocyte Chemoattractant Lymphokines: Mechanisms for the Amplification of Cell Mediated Immune Responses.”. The Effects of Histamine and Histamine-type 2 Antagonists in Inflamation and Immunodeficiency: R. Rocklin, ed. Marcel Dekker. NY,. 1988.
  30. Cruikshank WW, Berman JS, Theodore AC, Bernardo J, Center DM. Lymphokine activation of T4+ T lymphocytes and monocytes. J Immunol. 1987 Jun 1; 138(11):3817-23. PMID: 3108375.
    View in: PubMed
  31. Theodore AC, Beer DJ. Pharmacotherapy of chronic obstructive pulmonary disease. Clin Chest Med. 1986 Dec; 7(4):657-71. PMID: 2878760.
    View in: PubMed
  32. Theodore AC, Center DM, Cruikshank WW, Beer DJ. A human T-T-cell hybridoma-derived lymphocyte chemoattractant factor. Cell Immunol. 1986 Apr 1; 98(2):411-21. PMID: 3093096.
    View in: PubMed
  33. Theodore AC, Beer DJ. “Pharmacotherapy of Chronic Obstructive Pulmonary Disease.”. Pulmonary Rehabilitation: In Chest Clinics of North America;Ed. by B. Make. 1986; 7:657.
  34. Berman JS, Cruikshank WW, Center DM, Theodore AC, Beer DJ. Chemoattractant lymphokines specific for the helper/inducer T-lymphocyte subset. Cell Immunol. 1985 Oct 1; 95(1):105-12. PMID: 3161625.
    View in: PubMed
  35. Theodore AC, Frank JA, Ende J, Snider GL, Beer DJ. Errant placement of nasoenteric tubes. A hazard in obtunded patients. Chest. 1984 Dec; 86(6):931-3. PMID: 6499559.
    View in: PubMed
  36. Theodore AC, and Snider GL. The Solitary Pulmonary Nodule. J Respiratory Disease. 1984; 9(5):15-24.
  37. Theodore A, Wolff M. The effect of isoniazid on performance in school. Am Rev Respir Dis. 1970 Feb; 101(2):252-7. PMID: 4903772.
    View in: PubMed
  38. Khoury SA, Theodore A, Platte VJ. Isoniazid prophylaxis in a slum area. Am Rev Respir Dis. 1969 Mar; 99(3):345-53. PMID: 5304539.
    View in: PubMed
Arthur's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts
_
BU Co-Authors
_
Similar BU People
_
Same Department